Chlorpromazine Hydrochloride Injection
Product Images NDC 31722-367

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 31722-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlorpro25mgmlcartonlabel (Chlorpro25mgmlcartonlabel)

FDA Label Image

Chlorpro25mgmlcontainerlabel (Chlorpro25mgmlcontainerlabel)

FDA Label Image

Chlorpro50mg2mlcarton (Chlorpro50mg2mlcarton)

Chlorpro50mg2mlcarton (Chlorpro50mg2mlcarton)
Not available.*
FDA Label Image

Chlorpro50mg2mlcontainerlabel (Chlorpro50mg2mlcontainerlabel)

Chlorpro50mg2mlcontainerlabel (Chlorpro50mg2mlcontainerlabel)
This text appears to be a label from a medication packaging. It contains information about a drug called chlorpromazine HCI, which is an injection supplied by Camber Pharmaceuticals, Inc. The medication is meant for deep intramuscular use and should be protected from light. The label also includes details about the concentration of the drug and important contact information. Additionally, it mentions the expiration date and batch coding for quality control purposes. The medication is manufactured by Aspiro Pharma Limited in Telangana, India.*
FDA Label Image
FDA Label Image

Chlorpromazinestructure (Chlorpromazinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.